TRABER PETER G

CIK 00012845004 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001284500

Recent Transactions

50 trades

Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-09-25$1.06/sh−705→ 451,826 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.11/sh−20→ 446,121 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-05$1.13/sh−3,445→ 446,141 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.13/sh−8,164→ 449,601 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-04$1.14/sh−15→ 449,586 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2023-01-02+200,000→ 457,765 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2023-01-02+900,000→ 900,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2022-01-10+65,430→ 149,190 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-05$3.09/sh−3,226→ 251,355 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2022-01-03+415,900→ 415,900 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2022-01-03+90,200→ 254,581 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-10$2.99/sh−4,083→ 164,381 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-12-08+13,750→ 168,464 total
Sale
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-10-13$4.39/sh−3,636→ 154,714 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-10-01+13,750→ 158,350 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2021-09-24+54,400→ 54,400 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-09-24+9,100→ 144,600 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-05-26$3.99/sh+20,000→ 135,500 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-05-25$3.48/sh+5,000→ 115,500 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-05-24$3.32/sh+12,500→ 110,500 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-03-18$4.50/sh+10,000→ 98,000 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-03-17$4.53/sh+10,000→ 88,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2021-01-11+37,735→ 83,760 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2021-01-04+230,000→ 230,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2021-01-04+38,000→ 78,000 total
Purchase
Cartesian Therapeutics, Inc.$RNAC
Common Stock
2020-12-14$3.24/sh+40,000→ 40,000 total
Award
Cartesian Therapeutics, Inc.$RNAC
Employee Stock Option (right to buy)
2020-08-01+650,000→ 650,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Restricted Stock Units
2020-01-13$3.28/sh+18,292→ 46,025 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Restricted Stock Units
2019-01-14$4.95/sh+12,121→ 27,733 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2019-01-08+8,747→ 15,612 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-13$0.87/sh+100,000→ 207,333 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-13$7.51/sh−100,000→ 107,333 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-13−100,000→ 50,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-08$5.86/sh−70,000→ 107,333 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2018-06-08$0.87/sh+70,000→ 177,333 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-06-08−70,000→ 150,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-05-22+125,000→ 125,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2018-01-15+125,000→ 125,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2017-05-16+2,565→ 6,865 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Options to Purchase Common Stock
2017-01-09+2,750→ 2,750 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2017-01-09+1,650→ 4,300 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2016-12-03+220,000→ 220,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Options to Purchase Common Stock
2016-06-22+12,500→ 12,500 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2016-06-22+7,500→ 26,500 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Options to Purchase Common Stock
2016-01-25+15,000→ 15,000 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock
2016-01-25+9,000→ 19,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2016-01-20+134,000→ 134,000 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2015-08-12$2.00/sh+2,000→ 107,333 total
Award
LISATA THERAPEUTICS, INC.$LSTA
Common Stock, par value $0.001 per share
2015-06-02+10,000→ 10,000 total
Purchase
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2015-06-01$2.53/sh+4,000→ 105,333 total

Companies

Recent Filings

Address

C/O PRO-PHARMACEUTICALS, INC. 7 WELLS AVENUE, SUITE 34

NEWTON, MA, 02459

View on SEC.gov